📷 Image: Wikimedia Commons / Archies2804
Health
Overpriced Medical Supplies at AIIMS Bhopal: ₹14 Tube Bought for ₹943, Prices Up to 6500% Higher
✍️ Amar Ujala · Bhopal
🗓 29 Oct 2026, 10:45 AM
👁 23
An audit of AIIMS Bhopal’s procurement records shows a medical tube priced at ₹14.27 was purchased for ₹943.49, with more than 125 medicines and 200 surgical items listed at 500%‑6500% above market rates.
An internal audit of the All India Institute of Medical Sciences (AIIMS) in Bhopal has uncovered striking price discrepancies in its recent medical‑supply purchases. A simple catheter tube that should cost around ₹14.27 was recorded as bought for ₹943.49, representing a price increase of more than 6,500 percent.
The audit also identified over 125 pharmaceutical products and more than 200 surgical items whose quoted rates were between five and sixty‑five times higher than prevailing market prices. These findings suggest systematic over‑pricing across a broad range of essential health commodities.
Officials of AIIMS Bhopal have not provided an explanation for the inflated figures, and attempts to obtain comments were met with silence. The irregularities raise concerns about procurement transparency and the potential misuse of public funds allocated for healthcare.
The report, originally published by Amar Ujala, calls for a thorough investigation by relevant oversight bodies to determine the cause of the anomalies and to ensure accountability in the institute’s supply chain management.
The audit also identified over 125 pharmaceutical products and more than 200 surgical items whose quoted rates were between five and sixty‑five times higher than prevailing market prices. These findings suggest systematic over‑pricing across a broad range of essential health commodities.
Officials of AIIMS Bhopal have not provided an explanation for the inflated figures, and attempts to obtain comments were met with silence. The irregularities raise concerns about procurement transparency and the potential misuse of public funds allocated for healthcare.
The report, originally published by Amar Ujala, calls for a thorough investigation by relevant oversight bodies to determine the cause of the anomalies and to ensure accountability in the institute’s supply chain management.